We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

149 hedge funds and large institutions have $115M invested in Heron Therapeutics in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 48 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

6% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 48

7.94% less ownership

Funds ownership: 90.51% → 82.56% (-7.9%)

8% less funds holding

Funds holding: 162 → 149 (-13)

30% less capital invested

Capital invested by funds: $163M → $115M (-$48.3M)

45% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 29

67% less call options, than puts

Call options by funds: $20K | Put options by funds: $60K

Holders
149
Holders Change
-13
Holders Change %
-8.02%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
16
Increased
45
Reduced
48
Closed
29
Calls
$20K
Puts
$60K
Net Calls
-$40K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
JAM
JW Asset Management
Florida
+$3.94M
2
TCM
Tang Capital Management
California
+$2.32M
3
JFG
Jefferies Financial Group
New York
+$2.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.78M
5
CC
Clearline Capital
New York
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$7.87M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$5.9M
3
DTC
Deep Track Capital
Connecticut
-$2.05M
4
GPP
Great Point Partners
Connecticut
-$1.93M
5
BlackRock
BlackRock
New York
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
126
Steward Partners Investment Advisory
New York
$1.16K – – –
Carson Wealth (CWM LLC)
127
Carson Wealth (CWM LLC)
Nebraska
$1K -$119 -67 -13%
BCV
128
Banque Cantonale Vaudoise
Switzerland
$1K – – –
WAS
129
Winch Advisory Services
Wisconsin
$1K – – –
BG
130
Bollard Group
Massachusetts
$1K +$1.71K +956 New
LWP
131
Lumature Wealth Partners
Georgia
$969 – – –
PA
132
Parallel Advisors
California
$955 – – –
KT
133
Kevin Tang
$882 – – –
National Bank of Canada
134
National Bank of Canada
Quebec, Canada
$690 – – –
CB
135
CNB Bank
Pennsylvania
$580 – – –
NECFA
136
New England Capital Financial Advisors
Connecticut
$551 – – –
HNB
137
Huntington National Bank
Ohio
$429 – – –
WTA
138
Washington Trust Advisors
Massachusetts
$426 – – –
EBA
139
Eagle Bay Advisors
New York
$224 – – –
BHWM
140
Beaird Harris Wealth Management
Texas
$172 – – –
AF
141
Advisornet Financial
Minnesota
$128 – – –
EWM
142
Evermay Wealth Management
Virginia
$116 – – –
FFA
143
Farther Finance Advisors
California
$116 +$178 +100 New
GWSG
144
GPS Wealth Strategies Group
Colorado
$84 – – –
NC
145
NewSquare Capital
Pennsylvania
$46 – – –
FGAM
146
Financial Gravity Asset Management
Texas
$46 +$2 +1 New
Point72 Asset Management
147
Point72 Asset Management
Connecticut
$26 -$60.7K -34,012 -100%
WP
148
Woodline Partners
California
– -$860K -569,212 Closed
HF
149
HRT Financial
New York
– -$826K -547,365 Closed
Wellington Management Group
150
Wellington Management Group
Massachusetts
– -$472K -312,286 Closed
4 5
6
7 8

HRTX Hedge Fund Activity: Q2 2023 in Review

149 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2023, worth a combined $115M — down 30% from $163M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of HRTX and 16 opened new positions — a net loss of 13 holders — while 48 trimmed existing stakes and 45 added.

The largest buyer was JW Asset Management, opening a new position worth an estimated $3.94M. The largest seller was Franklin Resources, cutting an estimated $7.87M.

  • 149 institutional investors held Heron Therapeutics (HRTX) as of Q2 2023, down from 162 in Q1 2023.
  • Funds reported $115M of Heron Therapeutics stock for Q2 2023, down 30% quarter-over-quarter.
  • 16 funds opened new Heron Therapeutics positions in Q2 2023 and 29 closed out, a net change of -13 holders.
  • The largest Heron Therapeutics buyer in Q2 2023 was JW Asset Management, an estimated $3.94M added.
  • The largest Heron Therapeutics seller in Q2 2023 was Franklin Resources, an estimated $7.87M sold.

Based on aggregated 13F filings for Q2 2023.